Assessment of clinically actionable pharmacogenetic markers to stratify anti-seizure medications
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Assessment of clinically actionable pharmacogenetic markers to stratify anti-seizure medications
Authors
Keywords
-
Journal
PHARMACOGENOMICS JOURNAL
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-08-26
DOI
10.1038/s41397-023-00313-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potential role of regulatory DNA variants in modifying the risk of severe cutaneous reactions induced by aromatic anti‐seizure medications
- (2022) Kerry A. Mullan et al. EPILEPSIA
- Associations of HLA genetic variants with carbamazepine‐induced cutaneous adverse drug reactions: An updated meta‐analysis
- (2022) Mohitosh Biswas et al. CTS-Clinical and Translational Science
- A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam
- (2022) Ciarán Campbell et al. EPILEPSIA
- Pharmacogenomics polygenic risk score for drug response prediction using PRS-PGx methods
- (2022) Song Zhai et al. Nature Communications
- CADD-Splice—improving genome-wide variant effect prediction using deep learning-derived splice scores
- (2021) Philipp Rentzsch et al. Genome Medicine
- An Evidence‐Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine
- (2021) Michelle Whirl‐Carrillo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Associations between CYP3A4, CYP3A5 and SCN1A polymorphisms and carbamazepine metabolism in epilepsy: A meta-analysis
- (2021) Gui-Xin Zhao et al. EPILEPSY RESEARCH
- A meta-analysis of effects of CYP2C9 and CYP2C19 polymorphisms on phenytoin pharmacokinetic parameters
- (2021) Juntip Kanjanasilp et al. PHARMACOGENOMICS
- Spectrum of cutaneous adverse reactions to aromatic antiepileptic drugs and human leukocyte antigen genotypes in Thai patients and meta-analysis
- (2021) Chonlaphat Sukasem et al. PHARMACOGENOMICS JOURNAL
- Role of Common Genetic Variants for Drug-Resistance to Specific Anti-Seizure Medications
- (2021) Stefan Wolking et al. Frontiers in Pharmacology
- Assessing the role of rare genetic variants in drug‐resistant, non‐lesional focal epilepsy
- (2021) Stefan Wolking et al. Annals of Clinical and Translational Neurology
- Association of ABCB1 polymorphisms with carbamazepine metabolism and resistance in epilepsy: A meta-analysis
- (2021) Yu-Xin Fan et al. EPILEPSY RESEARCH
- The association between HLA-B*15:02 and phenytoin-induced severe cutaneous adverse reactions: a meta-analysis
- (2021) Thanh Huong Phung et al. PHARMACOGENOMICS
- Pharmacogenomics in Asian subpopulations and impacts on commonly prescribed medications
- (2020) Cody Lo et al. CTS-Clinical and Translational Science
- From Genetic Testing to Precision Medicine in Epilepsy
- (2020) Pasquale Striano et al. Neurotherapeutics
- Antiepileptic Drug Teratogenicity and De Novo Genetic Variation Load
- (2020) Piero Perucca et al. ANNALS OF NEUROLOGY
- Evaluation of adverse drug reaction profile of antiepileptic drugs in persons with epilepsy: A cross-sectional study
- (2020) Sachin Kumar et al. EPILEPSY & BEHAVIOR
- The mutational constraint spectrum quantified from variation in 141,456 humans
- (2020) Konrad J. Karczewski et al. NATURE
- Mechanisms of action of currently used antiseizure drugs
- (2020) Graeme J. Sills et al. NEUROPHARMACOLOGY
- Pharmacoresponse in genetic generalized epilepsy: a genome-wide association study
- (2020) Stefan Wolking et al. PHARMACOGENOMICS
- Mood‐Stabilizing Antiepileptic Treatment Response in Bipolar Disorder: A Genome‐Wide Association Study
- (2020) Ada Man‐Choi Ho et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- An update on CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects
- (2020) Wan-Chun Chang et al. Expert Opinion on Drug Metabolism & Toxicology
- Shared genetic risk factors across carbamazepine‐induced hypersensitivity reactions
- (2019) Paola Nicoletti et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Star Allele-Based Haplotyping versus Gene-Wise Variant Burden Scoring for Predicting 6-Mercaptopurine Intolerance in Pediatric Acute Lymphoblastic Leukemia Patients
- (2019) Yoomi Park et al. Frontiers in Pharmacology
- Global Text Mining and Development of Pharmacogenomic Knowledge Resource for Precision Medicine
- (2019) Debleena Guin et al. Frontiers in Pharmacology
- HLA‐B*51:01 and CYP2C9*3 Are Risk Factors for Phenytoin‐Induced Eruption in the Japanese Population: Analysis of Data From the Biobank Japan Project
- (2019) Keiko Hikino et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update
- (2018) Elizabeth J. Phillips et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The association between CYP2C9/2C19 polymorphisms and phenytoin maintenance doses in Asian epileptic patients: A systematic review and meta-analysis
- (2018) Kai Liao et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Pharmacogenomics in epilepsy
- (2018) Simona Balestrini et al. NEUROSCIENCE LETTERS
- Association between HLA alleles and lamotrigine-induced cutaneous adverse drug reactions in Asian populations: A meta-analysis
- (2018) Yilun Deng et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Replicability and Prediction: Lessons and Challenges from GWAS
- (2018) Urko M. Marigorta et al. TRENDS IN GENETICS
- Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population
- (2018) Taisei Mushiroda et al. JAMA Neurology
- An optimized prediction framework to assess the functional impact of pharmacogenetic variants
- (2018) Yitian Zhou et al. PHARMACOGENOMICS JOURNAL
- ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology
- (2017) Ingrid E. Scheffer et al. EPILEPSIA
- Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis
- (2017) Ping Wang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Genetic variation inCFHpredicts phenytoin-induced maculopapular exanthema in European-descent patients
- (2017) Mark McCormack et al. NEUROLOGY
- Association of the HLA-B alleles with carbamazepine-induced Stevens–Johnson syndrome/toxic epidermal necrolysis in the Javanese and Sundanese population of Indonesia: the important role of the HLA-B75 serotype
- (2017) Rika Yuliwulandari et al. PHARMACOGENOMICS
- Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population
- (2017) Elena Ramírez et al. PHARMACOLOGICAL RESEARCH
- The association of SCN1A p.Thr1067Ala polymorphism with epilepsy risk and the response to antiepileptic drugs in Slovenian children and adolescents with epilepsy
- (2017) Sara Bertok et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Outcomes in newly diagnosed epilepsy in adolescents and adults: Insights across a generation in Scotland
- (2017) Martin J. Brodie SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Impact ofMTHFR(C677T) gene polymorphism on antiepileptic drug monotherapy in North Indian epileptic population
- (2015) Murali Munisamy et al. ANNALS OF SAUDI MEDICINE
- GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy
- (2015) Hui Won Jang et al. EPILEPSY RESEARCH
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
- (2015) Sue Richards et al. GENETICS IN MEDICINE
- Genetic screening for human leukocyte antigen alleles prior to carbamazepine treatment
- (2015) Jeremy C.K. Tan et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Association ofABCB1C3435T polymorphism with phenobarbital resistance in Thai patients with epilepsy
- (2015) T. Keangpraphun et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs
- (2015) Lavinia Athanasiu et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A global reference for human genetic variation
- (2015) Richard A. Gibbs et al. NATURE
- Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients
- (2015) Armond Daci et al. PLoS One
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing
- (2014) K E Caudle et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- HLA-B*15:02 association with carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in an Indian population: a pooled-data analysis and meta-analysis
- (2014) Amy Hui-Ping Khor et al. EPILEPSIA
- Genetic Variants Associated With Phenytoin-Related Severe Cutaneous Adverse Reactions
- (2014) Wen-Hung Chung et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of a HLA-B*15:02 screening policy on antiepileptic drug use and severe skin reactions
- (2014) Z. Chen et al. NEUROLOGY
- The IPD and IMGT/HLA database: allele variant databases
- (2014) James Robinson et al. NUCLEIC ACIDS RESEARCH
- Pharmacogenomics of neuropsychiatric disorders: analysis of genetic variability in 162 identified neuroreceptors using 1000 Genomes Project data
- (2014) Harpreet Kaur et al. PHARMACOGENOMICS
- Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy
- (2014) Chun-Lai Ma et al. PHARMACOGENOMICS
- Pharmacogenetics of antiepileptic drug-induced hypersensitivity
- (2014) Katarzyna M Bloch et al. PHARMACOGENOMICS
- Association between the HLA-B*15:02 allele and carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Han individuals of northeastern China
- (2014) Xiao-Jing He et al. Pharmacological Reports
- Drug treatment of epilepsy in adults
- (2014) D. Schmidt et al. BMJ-British Medical Journal
- Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Carbamazepine Dosing
- (2013) S G Leckband et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese
- (2013) Ying-Kit Cheung et al. EPILEPSIA
- The puzzle(s) of pharmacoresistant epilepsy
- (2013) Bernd Pohlmann-Eden et al. EPILEPSIA
- Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes
- (2013) Tracy Glauser et al. EPILEPSIA
- Genotype–phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: Strength and clinical correlations
- (2013) Yi-Hsin Hsiao et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- New avenues for anti-epileptic drug discovery and development
- (2013) Wolfgang Löscher et al. NATURE REVIEWS DRUG DISCOVERY
- HLA alleles and hypersensitivity to carbamazepine
- (2013) Sandeep Grover et al. Pharmacogenetics and Genomics
- SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis
- (2013) Batoul Sadat Haerian et al. PHARMACOGENOMICS
- HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis
- (2013) E Genin et al. PHARMACOGENOMICS JOURNAL
- Interpreting the clinical utility of a pharmacogenomic marker based on observational association studies
- (2013) M J Sorich et al. PHARMACOGENOMICS JOURNAL
- Visualizing genomic information across chromosomes with PhenoGram
- (2013) Daniel Wolfe et al. BioData Mining
- Pharmacogenomics Knowledge for Personalized Medicine
- (2012) M Whirl-Carrillo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Second-generation antiepileptic drugs and pregnancy: a guide for clinicians
- (2012) Arne Reimers et al. Expert Review of Neurotherapeutics
- Annotation of functional variation in personal genomes using RegulomeDB
- (2012) A. P. Boyle et al. GENOME RESEARCH
- An Algorithm to Detect Adverse Drug Reactions in the Neonatal Intensive Care Unit
- (2012) Wei Du et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Christopher J L Murray et al. LANCET
- Association of CYP2C9 polymorphisms with phenytoin toxicity in Indian patients
- (2012) UrmilaM Thatte et al. NEUROLOGY INDIA
- Genome-wide mapping for clinically relevant predictors of lamotrigine- and phenytoin-induced hypersensitivity reactions
- (2012) Mark McCormack et al. PHARMACOGENOMICS
- Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy
- (2012) Yogita Ghodke Puranik et al. PHARMACOGENOMICS
- Relating human genetic variation to variation in drug responses
- (2012) Ashraf G. Madian et al. TRENDS IN GENETICS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing
- (2011) M V Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans
- (2011) Sae-Hoon Kim et al. EPILEPSY RESEARCH
- Genomics and Drug Response
- (2011) Liewei Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenomics and epilepsy: the road ahead
- (2011) Gianpiero L Cavalleri et al. PHARMACOGENOMICS
- Efficacy of New Antiepileptic Drugs
- (2011) Dieter Schmidt Epilepsy Currents
- Levetiracetam in the treatment of epilepsy
- (2011) Bassel Abou-Khalil Neuropsychiatric Disease and Treatment
- HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain
- (2011) Kongkiat Kulkantrakorn et al. Pain Practice
- Absence of a general association between ABCB1 genetic variants and response to antiepileptic drugs in epilepsy patients
- (2010) Sandeep Grover et al. BIOCHIMIE
- Pharmacogenetics and Antiepileptic Drugs
- (2010) Brian B. Spear EPILEPSIA
- Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population
- (2010) Takeshi Ozeki et al. HUMAN MOLECULAR GENETICS
- A method and server for predicting damaging missense mutations
- (2010) Ivan A Adzhubei et al. NATURE METHODS
- Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations
- (2010) F. F. Gonzalez-Galarza et al. NUCLEIC ACIDS RESEARCH
- Management of refractory complex partial seizures: current state of the art
- (2010) David Treiman Neuropsychiatric Disease and Treatment
- Differential role of sodium channelsSCN1AandSCN2Agene polymorphisms with epilepsy and multiple drug resistance in the north Indian population
- (2009) Ram Lakhan et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- HLA Class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions
- (2009) Hiroko Ikeda et al. EPILEPSIA
- Failure to Replicate a Genetic Association May Provide Important Clues About Genetic Architecture
- (2009) Casey S. Greene et al. PLoS One
- The clinical impact of pharmacogenetics on the treatment of epilepsy
- (2008) Wolfgang Löscher et al. EPILEPSIA
- No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population
- (2008) R. Lakhan et al. EPILEPSY & BEHAVIOR
- The influence of C3435T polymorphism of ABCB1 gene on penetration of phenobarbital across the blood–brain barrier in patients with generalized epilepsy
- (2008) Silvio Basic et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started